What are the risks of serious infections and malignancies for patients treated with anti-tumor necrosis factor antibodies?
Corona
Rosamaria
R
Istituto Dermopatico dell'Immacolata, Rome, Italy. r.corona@idi.it
Bigby
Michael
M